Year archive

ARGENICA THERAPEUTICS LIMITED — 2021 filings

All 44 regulatory filings released by ARGENICA THERAPEUTICS LIMITED (AGN) in 2021, sourced directly from the official regulator.

44 Filings

2021 Period

2021 filings (44)

Filing	Released	Lang
Application for quotation of securities - AGN 6 pages 27.1KB Share Issue/Capital Change	2021-12-30	English
Application for quotation of securities - AGN 6 pages 27.2KB Share Issue/Capital Change	2021-12-16	English
Release of Restricted Securities from Escrow 1 page Regulatory Filings	2021-12-09	English
Argenica to be Granted Patent Protection in the US 3 pages 237.6KB Regulatory Filings	2021-12-08	English
AGM Presentation 16 pages 2.9MB AGM Information	2021-11-16	English
Results of Annual General Meeting 2 pages 247.8KB Declaration of Voting Results & Voting Rights Announcements	2021-11-16	English
Positive Preclinical Data for ARG-007 Neuroprotection in HIE 6 pages 618.8KB Regulatory Filings	2021-11-02	English
Quarterly Activities/Appendix 4C Cash Flow Report 11 pages 456.2KB Interim / Quarterly Report	2021-10-27	English
Investor Presentation 16 pages 3.1MB Investor Presentation	2021-10-26	English
Phase 1 Clinical Trial Overview & Roadmap 20 pages 4.2MB Investor Presentation	2021-10-17	English
Notice of Annual General Meeting/Proxy Form 20 pages 573.5KB AGM Information	2021-10-14	English
Application for quotation of securities - AGN 6 pages 27.1KB Capital/Financing Update	2021-10-13	English
Release of Restricted Securities from Escrow 1 page Capital/Financing Update	2021-10-03	English
Argenica Partners With Linear For Phase 1 Clinical Trial 3 pages 272.0KB Regulatory Filings	2021-09-29	English
Date of AGM & Closing Date for Director Nominations 2 pages 259.8KB AGM Information	2021-09-20	English
Argenica Achieves Manufacturing Milestones 3 pages 425.9KB Capital/Financing Update	2021-09-13	English
Appendix 4E & Annual Report 30 June 2021 47 pages 1.2MB Annual Report	2021-08-26	English
Appendix 4G & Corporate Governance Statement 24 pages 526.4KB Regulatory Filings	2021-08-26	English
Appendix 3G 18 pages 392.2KB Capital/Financing Update	2021-08-10	English
Issue of Options 3 pages 308.0KB Capital/Financing Update	2021-08-04	English
Proposed issue of securities - AGN 5 pages 28.6KB Capital/Financing Update	2021-08-04	English
Quarterly Activities/Appendix 4C Cash Flow Report 12 pages 519.3KB Interim / Quarterly Report	2021-07-28	English
Grant Secured to Advance Pre-Clinical Studies Of ARG-007 4 pages 314.0KB Regulatory Filings	2021-07-20	English
Study Additional Information 3 pages 210.4KB Regulatory Filings	2021-07-12	English
Study Shows ARG-007 Does Not Degrade 3 pages 339.0KB Regulatory Filings	2021-07-11	English
Argenica Completes Pilot Pre-Clinical Pharmacokinetics Study 2 pages 258.1KB Regulatory Filings	2021-06-30	English
Change of Registered Office 1 page 188.5KB Regulatory Filings	2021-06-29	English
Investor Presentation 25 pages 3.4MB Investor Presentation	2021-06-15	English
Argenica Commences Trading on ASX 4 pages 452.5KB Capital/Financing Update	2021-06-10	English
ASX Notice - Admission to Official List 2 pages 94.3KB Regulatory Filings	2021-06-08	English
Appendix 1A & Information Form and Checklist 18 pages 359.5KB Regulatory Filings	2021-06-08	English
Prospectus 105 pages 5.0MB Regulatory Filings	2021-06-08	English
Constitution 63 pages 807.3KB Governance Information	2021-06-08	English
Annual Report for period from incorporation to 30 June 2020 23 pages 656.8KB Annual Report	2021-06-08	English
Interim Report for the period ended 31 December 2020 14 pages 571.9KB Interim / Quarterly Report	2021-06-08	English
Employee Securities Incentive Plan 31 pages 594.9KB Remuneration Information	2021-06-08	English
Corporate Governance Statement 10 pages 294.1KB Governance Information	2021-06-08	English
Securities Trading Policy 11 pages 149.2KB Governance Information	2021-06-08	English
Distribution Schedule 1 page 11.3KB Major Shareholding Notification	2021-06-08	English
Top 20 Holders 2 pages 13.4KB Major Shareholding Notification	2021-06-08	English
Confirmation Statements 2 pages 251.1KB Capital/Financing Update	2021-06-08	English
Initial Director's Interest Notice x4 8 pages 277.7KB Director's Dealing	2021-06-08	English
Becoming a substantial holder 2 pages 311.4KB Major Shareholding Notification	2021-06-08	English
Becoming a substantial holder 2 pages 155.6KB Regulatory Filings	2021-06-08	English